239 related articles for article (PubMed ID: 28474124)
21. Cyclooxygenase-2 expression is associated with vascular endothelial growth factor-c and lymph node metastasis in human oral tongue cancer.
Morita Y; Morita N; Hata K; Nakanishi M; Kimoto N; Omata T; Nakamura Y; Yoneda T
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Apr; 117(4):502-10. PubMed ID: 24560404
[TBL] [Abstract][Full Text] [Related]
22. Detection of lymphovascular invasion by D2-40 (podoplanin) immunoexpression in endometrial cancer.
Weber SK; Sauerwald A; Pölcher M; Braun M; Debald M; Serce NB; Kuhn W; Brunagel-Walgenbach G; Rudlowski C
Int J Gynecol Cancer; 2012 Oct; 22(8):1442-8. PubMed ID: 22964524
[TBL] [Abstract][Full Text] [Related]
23. Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer.
Zhang XH; Huang DP; Guo GL; Chen GR; Zhang HX; Wan L; Chen SY
BMC Cancer; 2008 Jan; 8():4. PubMed ID: 18190720
[TBL] [Abstract][Full Text] [Related]
24. Lymphatic vessel involvement is predictive for lymph node metastasis and an important prognostic factor in endometrial cancer.
Wakayama A; Kudaka W; Matsumoto H; Aoyama H; Ooyama T; Taira Y; Arakaki Y; Shimoji Y; Nakasone T; Nishihira K; Kaneshima I; Tamaki T; Yoshimi N; Aoki Y
Int J Clin Oncol; 2018 Jun; 23(3):532-538. PubMed ID: 29275449
[TBL] [Abstract][Full Text] [Related]
25. Multivariate independent prognostic factors in endometrial carcinoma: a clinicopathologic study in 181 patients: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University.
Steiner E; Eicher O; Sagemüller J; Schmidt M; Pilch H; Tanner B; Hengstler JG; Hofmann M; Knapstein PG
Int J Gynecol Cancer; 2003; 13(2):197-203. PubMed ID: 12657124
[TBL] [Abstract][Full Text] [Related]
26. Multivariate analysis by Cox proportional hazard model on prognosis of patient with epithelial ovarian cancer.
Wang M; He Y; Shi L; Shi C
Eur J Gynaecol Oncol; 2011; 32(2):171-7. PubMed ID: 21614907
[TBL] [Abstract][Full Text] [Related]
27. [Clinical implications of positive peritoneal cytology in endometrial cancer].
Ren YL; Wang HY; Shan BE; Ping B; Shi DR
Zhonghua Fu Chan Ke Za Zhi; 2011 Aug; 46(8):595-9. PubMed ID: 22169518
[TBL] [Abstract][Full Text] [Related]
28. Vascular endothelial growth factor-C associated with computed tomography used in the diagnosis of lymph node metastasis of bladder carcinoma.
Li Z; Qi F; Miao J; Zu X; He W; Wang L; Qi L
Arch Med Res; 2010 Nov; 41(8):606-10. PubMed ID: 21199729
[TBL] [Abstract][Full Text] [Related]
29. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
30. [Study on cytokeratin and CA125 for diagnosing lymph node micrometastases in endometrial cancer].
Liu FH; Wang YF; Wang J; Xue Q; Jiang S; Ma YY
Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):612-5. PubMed ID: 15498190
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological significance of vascular endothelial growth factor-C and cyclooxygenase-2 in esophageal squamous cell carcinoma.
Byeon JS; Jung HY; Lee YJ; Lee D; Lee GH; Myung SJ; Yang SK; Hong WS; Kim JH; Min YI; Kim JS
J Gastroenterol Hepatol; 2004 Jun; 19(6):648-54. PubMed ID: 15151619
[TBL] [Abstract][Full Text] [Related]
32. COX-2 expression is correlated with VEGF-C, lymphangiogenesis and lymph node metastasis in human cervical cancer.
Liu H; Xiao J; Yang Y; Liu Y; Ma R; Li Y; Deng F; Zhang Y
Microvasc Res; 2011 Sep; 82(2):131-40. PubMed ID: 21600223
[TBL] [Abstract][Full Text] [Related]
33. Expressions of p53, VEGF C, p21: could they be used in preoperative evaluation of lymph node metastasis of esophageal squamous cell carcinoma?
Han U; Can OI; Han S; Kayhan B; Onal BU
Dis Esophagus; 2007; 20(5):379-85. PubMed ID: 17760650
[TBL] [Abstract][Full Text] [Related]
34. The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology.
Chi DS; Barakat RR; Palayekar MJ; Levine DA; Sonoda Y; Alektiar K; Brown CL; Abu-Rustum NR
Int J Gynecol Cancer; 2008; 18(2):269-73. PubMed ID: 18334008
[TBL] [Abstract][Full Text] [Related]
35. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
36. [The effect of cyclooxygenase-2 on lymphangiogenesis in breast cancer].
Guo GL; Yang GL; Li ZY; You J; Yang K; Huang DP; Hu XQ; Zhang XH
Zhonghua Wai Ke Za Zhi; 2008 Jan; 46(2):132-5. PubMed ID: 18509974
[TBL] [Abstract][Full Text] [Related]
37. Angiostatin expression in endometrial cancer.
Yabushita H; Noguchi M; Kinoshita S; Kishida T; Sawaguchi K; Noguchi M
Oncol Rep; 2002; 9(6):1193-6. PubMed ID: 12375018
[TBL] [Abstract][Full Text] [Related]
38. Expression of vascular endothelial growth factor (VEGF)-D and its receptor, VEGF receptor 3, as a prognostic factor in endometrial carcinoma.
Yokoyama Y; Charnock-Jones DS; Licence D; Yanaihara A; Hastings JM; Holland CM; Emoto M; Sakamoto A; Sakamoto T; Maruyama H; Sato S; Mizunuma H; Smith SK
Clin Cancer Res; 2003 Apr; 9(4):1361-9. PubMed ID: 12684405
[TBL] [Abstract][Full Text] [Related]
39. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy.
Nelson G; Randall M; Sutton G; Moore D; Hurteau J; Look K
Gynecol Oncol; 1999 Nov; 75(2):211-4. PubMed ID: 10525373
[TBL] [Abstract][Full Text] [Related]
40. The clinical significance of coexpression of cyclooxygenases-2, vascular endothelial growth factors, and epidermal growth factor receptor in nasopharyngeal carcinoma.
Pan J; Kong L; Lin S; Chen G; Chen Q; Lu JJ
Laryngoscope; 2008 Nov; 118(11):1970-5. PubMed ID: 18758376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
